JP Morgan Chase
MGNX icon

JP Morgan Chase’s MacroGenics MGNX Stock Holding History

JP Morgan Chase’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-100
Closed -$3K – 6668
2021
Q2 		$3K Sell
100
-12,600
-99% -$369K ﹤0.01% 6180
2021
Q1 		$404K Buy
+12,700
New +$308K ﹤0.01% 4812

Other funds holding MGNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

JP Morgan Chase's MGNX Position: Q2 2026 in Review

JP Morgan Chase increased its MacroGenics (MGNX) stake by 11% in Q2 2026, buying an estimated $9.82K and bringing the position to 26,371 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #5868.

JP Morgan Chase first reported a position in MGNX in Q4 2013 and has held it in 51 quarters since. The position peaked at $15.1M in Q1 2024. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • JP Morgan Chase held 26,371 shares of MacroGenics worth $128K as of Q2 2026.
  • JP Morgan Chase bought 2,596 MacroGenics shares in Q2 2026, an estimated $9.82K.
  • MacroGenics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5868 holding.
  • JP Morgan Chase first reported a position in MacroGenics in Q4 2013 and has held it in 51 quarters since.
  • JP Morgan Chase's MacroGenics position peaked at $15.1M in Q1 2024.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.